MedPath

Acupuncture First for IC/BPS

Not Applicable
Recruiting
Conditions
Bladder Pain Syndrome
Interstitial Cystitis
Interventions
Other: Acupuncture
Behavioral: Behavioral management
Other: Physical therapy
Registration Number
NCT06366269
Lead Sponsor
University Hospitals Cleveland Medical Center
Brief Summary

The goal of this clinical trial is to learn if acupuncture in addition to behavioral changes can better treat in women with bladder pain syndrome (also known as interstitial cystitis) that have not received other treatments. The main question it aims to answer is:

Does acupuncture improve pain symptoms on the Interstitial Cystitis Index? Researchers will compare six (6) weeks behavioral management alone to behavioral management and acupuncture.

Participants will

* complete surveys about their bladder pain symptoms

* make behavioral changes that have been shown to improve bladder pain symptoms

* attend six (6) weekly acupuncture sessions

* attend six (6) weekly physical therapy sessions after finishing acupuncture

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Meets American Urologic Association (AUA) criteria for interstitial cystitis/bladder pain syndrome (IC/BPS): "An unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than 6 weeks duration, in the absence of other identifiable cause"
  • Negative urine culture
  • Has completed cystoscopic evaluation for IC/BPS
Exclusion Criteria
  • History of recurrent urinary tract infection (2 or more culture-positive in 6 months or 3 or more in 12 months)
  • History of overactive bladder
  • History of bleeding disorder or are currently on chronic anti-coagulation
  • Post-void residual >100mL
  • Has previously undergone any of the following treatments for any indication: acupuncture, pelvic floor physical therapy, pre-tibial nerve stimulation (PTNS), sacral neuromodulation, or intradetrusor Botox
  • Prior bladder augmentation
  • Currently undergoing or will undergo treatment for a urologic or gynecologic malignancy
  • Currently pregnant (if applicable, based on self-report)
  • Implanted pacemaker or defibrillator (AICD) or any metallic implants below umbilicus (eg hip or knee replacements)
  • Non-English speaking and reading

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AcupunctureAcupunctureParticipants will receive instruction (verbal and written) on recommended changes to diet and urinary habits to treat bladder pain. They will complete six (6) weekly one hour acupuncture sessions followed by pelvic floor physical therapy.
AcupuncturePhysical therapyParticipants will receive instruction (verbal and written) on recommended changes to diet and urinary habits to treat bladder pain. They will complete six (6) weekly one hour acupuncture sessions followed by pelvic floor physical therapy.
Behavioral ManagementPhysical therapyParticipants will receive instruction (verbal and written) on recommended changes to diet and urinary habits to treat bladder pain for six (6) weeks before starting pelvic floor physical therapy.
Behavioral ManagementBehavioral managementParticipants will receive instruction (verbal and written) on recommended changes to diet and urinary habits to treat bladder pain for six (6) weeks before starting pelvic floor physical therapy.
AcupunctureBehavioral managementParticipants will receive instruction (verbal and written) on recommended changes to diet and urinary habits to treat bladder pain. They will complete six (6) weekly one hour acupuncture sessions followed by pelvic floor physical therapy.
Primary Outcome Measures
NameTimeMethod
O'Leary-Sant Interstitial Cystitis Index (OLSICI)Baseline, every 2 weeks x3 (6 week study protocol period), every 4 weeks x 13 (52 week post-treatment period)

Validated 8-item questionnaire with reported scores ranging 0-37. Higher scores are consistent with worse symptoms.

Secondary Outcome Measures
NameTimeMethod
Genitourinary Pain Index (GUPI)Baseline, every 2 weeks x3 (6 week study protocol period), every 4 weeks x 13 (52 week post-treatment period)

Validated 9-item questionnaire with reported scores ranging 0-45. Higher scores are consistent with worse symptom control.

Number of additional treatments used during study period1 year post-treatment period

Treatments include pharmacotherapy, intradetrusor botox, neuromodulation, cyclosporine

Short Form (SF-36)x1 (end of 6 week study protocol period), x1 (end of 1 year post-treatment period)

Validated 36-item questionnaire. Higher scores are consistent with worse symptom control.

Patient Global Impression of Improvement (PGI-I)x1 (end of 6 week study protocol period), x1 (end of 1 year post-treatment period)

Validated 1-item likert-scale question on a scale from 1 (very much better) to 7 (very much worse).

Number of unscheduled interactions1 year post-treatment period

Unscheduled interactions include any phone calls, messages, or unplanned visits

Trial Locations

Locations (1)

University Hospitals

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath